Aristeia Capital’s AfterNext HealthTech Acquisition Corp AFTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,191,528
Closed -$22.7M 291
2023
Q2
$22.7M Buy
2,191,528
+147,952
+7% +$1.52M 0.5% 27
2023
Q1
$20.9M Buy
2,043,576
+353,682
+21% +$3.58M 0.49% 49
2022
Q4
$16.9M Buy
1,689,894
+855,238
+102% +$8.47M 0.34% 70
2022
Q3
$8.15M Buy
+834,656
New +$8.13M 0.14% 205

Aristeia Capital's AFTR Position: Q3 2023 in Review

Aristeia Capital sold out of AfterNext HealthTech Acquisition Corp (AFTR) in Q3 2023, closing a stake of 2,191,528 shares — an estimated $22.7M sold.

Aristeia Capital first reported a position in AFTR in Q3 2022 and held it in 4 quarters. The position peaked at $22.7M in Q2 2023. 0 funds tracked by Wall St. Rank hold AFTR as of Q3 2023.

  • Aristeia Capital reported no remaining AfterNext HealthTech Acquisition Corp position as of Q3 2023 after selling out during the quarter.
  • Aristeia Capital sold 2,191,528 AfterNext HealthTech Acquisition Corp shares in Q3 2023, an estimated $22.7M.
  • Aristeia Capital first reported a position in AfterNext HealthTech Acquisition Corp in Q3 2022 and held it in 4 quarters.
  • Aristeia Capital's AfterNext HealthTech Acquisition Corp position peaked at $22.7M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held AfterNext HealthTech Acquisition Corp as of Q3 2023.

Based on Aristeia Capital's 13F filing for Q3 2023, filed 14 Nov 2023.